HomeBXT • ETR
add
BioNxt Solutions Inc
Previous close
€0.35
Day range
€0.35 - €0.37
Year range
€0.12 - €0.41
Market cap
62.37M CAD
Avg Volume
20.19K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.83M | 36.22% |
Net income | -1.97M | -25.46% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.81M | -37.30% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 329.14K | 298.48% |
Total assets | 1.02M | 28.85% |
Total liabilities | 8.58M | 23.97% |
Total equity | -7.56M | — |
Shares outstanding | 116.96M | — |
Price to book | -4.97 | — |
Return on assets | -578.39% | — |
Return on capital | 205.52% | — |
Cash Flow
Net change in cash
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.97M | -25.46% |
Cash from operations | -1.32M | -33.19% |
Cash from investing | 83.20K | — |
Cash from financing | 1.53M | 116.29% |
Net change in cash | 296.79K | 205.60% |
Free cash flow | -2.74M | -346.93% |
About
Founded
2017
Headquarters
Website
Employees
20
